S. 252 

One Hundred Thirteenth Congress 

of the 

United States of America 

AT THE FIRST SESSION 

Begun and held at the City of Washington on Thursday, 

the third day of January, two thousand and thirteen 

An Act 

To reduce preterm labor and delivery and the risk of pregnancy-related deaths 

and complications due to pregnancy, and to reduce infant mortality caused by 

prematurity, and for other purposes. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. TABLE OF CONTENTS. 

The table of contents for this Act is as follows: 

Sec. 1. Table of contents. 

TITLE I—PREEMIE ACT REAUTHORIZATION 

Sec. 101. Short title. 

Sec. 102. Research and activities at the Centers for Disease Control and Prevention. 

Sec. 103. Activities at the Health Resources and Services Administration. 

Sec. 104. Other activities. 

TITLE II—NATIONAL PEDIATRIC RESEARCH NETWORK 

Sec. 201. Short title. 

Sec. 202. National Pediatric Research Network. 

TITLE III—CHIMP ACT AMENDMENTS 

Sec. 301. Short title. 

Sec. 302. Care for NIH chimpanzees. 

TITLE I—PREEMIE ACT 

REAUTHORIZATION 

SEC. 101. SHORT TITLE. 

This title may be cited as the ‘‘Prematurity Research Expansion 

and Education for Mothers who deliver Infants Early Reauthorization Act’’ or the ‘‘PREEMIE Reauthorization Act’’. 

SEC. 102. RESEARCH AND ACTIVITIES AT THE CENTERS FOR DISEASE 

CONTROL AND PREVENTION. 

(a) EPIDEMIOLOGICAL STUDIES.—Section 3 of the Prematurity 

Research Expansion and Education for Mothers who deliver Infants 

Early Act (42 U.S.C. 247b–4f) is amended by striking subsection 

(b) and inserting the following: 

‘‘(b) STUDIES AND ACTIVITIES ON PRETERM BIRTH.— 

‘‘(1) IN GENERAL.—The Secretary of Health and Human 

Services, acting through the Director of the Centers for Disease 

Control and Prevention, may, subject to the availability of 

appropriations— 
S. 252—2 

‘‘(A) conduct epidemiological studies on the clinical, 

biological, social, environmental, genetic, and behavioral 

factors relating to prematurity, as appropriate; 

‘‘(B) conduct activities to improve national data to 

facilitate tracking the burden of preterm birth; and 

‘‘(C) continue efforts to prevent preterm birth, including 

late preterm birth, through the identification of opportunities for prevention and the assessment of the impact of 

such efforts. 

‘‘(2) REPORT.—Not later than 2 years after the date of 

enactment of the PREEMIE Reauthorization Act, and every 

2 years thereafter, the Secretary of Health and Human Services, 

acting through the Director of the Centers for Disease Control 

and Prevention, shall submit to the appropriate committees 

of Congress reports concerning the progress and any results 

of studies conducted under paragraph (1).’’. 

(b) REAUTHORIZATION.—Section 3(e) of the Prematurity 

Research Expansion and Education for Mothers who deliver Infants 

Early Act (42 U.S.C. 247b–4f(e)) is amended by striking ‘‘$5,000,000’’ 

and all that follows through ‘‘2011.’’ and inserting ‘‘$1,880,000 for 

each of fiscal years 2014 through 2018.’’. 

SEC. 103. ACTIVITIES AT THE HEALTH RESOURCES AND SERVICES 

ADMINISTRATION. 

(a) TELEMEDICINE AND HIGH-RISK PREGNANCIES.—Section 

330I(i)(1)(B) of the Public Health Service Act (42 U.S.C. 254c– 

14(i)(1)(B)) is amended by striking ‘‘or case management services’’ 

and inserting ‘‘case management services, or prenatal care for highrisk pregnancies’’; 

(b) PUBLIC AND HEALTH CARE PROVIDER EDUCATION.—Section 

399Q of the Public Health Service Act (42 U.S.C. 280g–5) is 

amended— 

(1) in subsection (b)— 

(A) in paragraph (1), by striking subparagraphs (A) 

through (F) and inserting the following: 

‘‘(A) the core risk factors for preterm labor and delivery; 

‘‘(B) medically indicated deliveries before full term; 

‘‘(C) the importance of preconception and prenatal care, 

including— 

‘‘(i) smoking cessation; 

‘‘(ii) weight maintenance and good nutrition, 

including folic acid; 

‘‘(iii) the screening for and the treatment of infections; and 

‘‘(iv) stress management; 

‘‘(D) treatments and outcomes for premature infants, 

including late preterm infants; 

‘‘(E) the informational needs of families during the 

stay of an infant in a neonatal intensive care unit; and 

‘‘(F) utilization of evidence-based strategies to prevent 

birth injuries;’’; and 

(B) by striking paragraph (2) and inserting the following: 

‘‘(2) programs to increase the availability, awareness, and 

use of pregnancy and post-term information services that provide evidence-based, clinical information through counselors, 
S. 252—3 

community outreach efforts, electronic or telephonic communication, or other appropriate means regarding causes associated with prematurity, birth defects, or health risks to a postterm infant;’’; and 

(2) in subsection (c), by striking ‘‘$5,000,000’’ and all that 

follows through ‘‘2011.’’ and inserting ‘‘$1,900,000 for each of 

fiscal years 2014 through 2018.’’. 

SEC. 104. OTHER ACTIVITIES. 

(a) INTERAGENCY COORDINATING COUNCIL ON PREMATURITY AND

LOW BIRTHWEIGHT.—The Prematurity Research Expansion and 

Education for Mothers who deliver Infants Early Act is amended 

by striking section 5 (42 U.S.C. 247b–4g). 

(b) ADVISORY COMMITTEE ON INFANT MORTALITY.— 

(1) ESTABLISHMENT.—The Secretary of Health and Human 

Services (referred to in this section as the ‘‘Secretary’’) may 

establish an advisory committee known as the ‘‘Advisory Committee on Infant Mortality’’ (referred to in this section as the 

‘‘Advisory Committee’’). 

(2) DUTIES.—The Advisory Committee shall provide advice 

and recommendations to the Secretary concerning the following 

activities: 

(A) Programs of the Department of Health and Human 

Services that are directed at reducing infant mortality and 

improving the health status of pregnant women and 

infants. 

(B) Strategies to coordinate the various Federal programs and activities with State, local, and private programs 

and efforts that address factors that affect infant mortality. 

(C) Implementation of the Healthy Start program 

under section 330H of the Public Health Service Act (42 

U.S.C. 254c–8) and Healthy People 2020 infant mortality 

objectives. 

(D) Strategies to reduce preterm birth rates through 

research, programs, and education. 

(3) PLAN FOR HHS PRETERM BIRTH ACTIVITIES.—Not later 

than 1 year after the date of enactment of this section, the 

Advisory Committee (or an advisory committee in existence 

as of the date of enactment of this Act and designated by 

the Secretary) shall develop a plan for conducting and supporting research, education, and programs on preterm birth 

through the Department of Health and Human Services and 

shall periodically review and revise the plan, as appropriate. 

The plan shall— 

(A) examine research and educational activities that 

receive Federal funding in order to enable the plan to 

provide informed recommendations to reduce preterm birth 

and address racial and ethnic disparities in preterm birth 

rates; 

(B) identify research gaps and opportunities to implement evidence-based strategies to reduce preterm birth 

rates among the programs and activities of the Department 

of Health and Human Services regarding preterm birth, 

including opportunities to minimize duplication; and 

(C) reflect input from a broad range of scientists, 

patients, and advocacy groups, as appropriate. 
S. 252—4 

(4) MEMBERSHIP.—The Secretary shall ensure that the 

membership of the Advisory Committee includes the following: 

(A) Representatives provided for in the original charter 

of the Advisory Committee. 

(B) A representative of the National Center for Health 

Statistics. 

(c) PATIENT SAFETY STUDIES AND REPORT.— (1) IN GENERAL.—The Secretary shall designate an appropriate agency within the Department of Health and Human 

Services to coordinate existing studies on hospital readmissions 

of preterm infants. 

(2) REPORT TO SECRETARY AND CONGRESS.—Not later than 

1 year after the date of the enactment of this Act, the agency 

designated under paragraph (1) shall submit to the Secretary 

and to Congress a report containing the findings and recommendations resulting from the studies coordinated under 

such paragraph, including recommendations for hospital discharge and followup procedures designed to reduce rates of 

preventable hospital readmissions for preterm infants. 

TITLE II—NATIONAL PEDIATRIC 

RESEARCH NETWORK 

SEC. 201. SHORT TITLE. 

This title may be cited as the ‘‘National Pediatric Research 

Network Act of 2013’’. 

SEC. 202. NATIONAL PEDIATRIC RESEARCH NETWORK. 

Section 409D of the Public Health Service Act (42 U.S.C. 284h; 

relating to the Pediatric Research Initiative) is amended— 

(1) by redesignating subsection (d) as subsection (f); and 

(2) by inserting after subsection (c) the following: 

‘‘(d) NATIONAL PEDIATRIC RESEARCH NETWORK.— 

‘‘(1) NETWORK.—In carrying out the Initiative, the Director 

of NIH, in consultation with the Director of the Eunice Kennedy 

Shriver National Institute of Child Health and Human Development and in collaboration with other appropriate national 

research institutes and national centers that carry out activities 

involving pediatric research, may provide for the establishment 

of a National Pediatric Research Network in order to more 

effectively support pediatric research and optimize the use of 

Federal resources. Such National Pediatric Research Network 

may be comprised of, as appropriate— 

‘‘(A) the pediatric research consortia receiving awards 

under paragraph (2); or 

‘‘(B) other consortia, centers, or networks focused on 

pediatric research that are recognized by the Director of 

NIH and established pursuant to the authorities vested 

in the National Institutes of Health by other sections of 

this Act. 

‘‘(2) PEDIATRIC RESEARCH CONSORTIA.— 

‘‘(A) IN GENERAL.—The Director of NIH may award 

funding, including through grants, contracts, or other 

mechanisms, to public or private nonprofit entities for providing support for pediatric research consortia, including 

with respect to— 
S. 252—5 

‘‘(i) basic, clinical, behavioral, or translational 

research to meet unmet needs for pediatric research; 

and 

‘‘(ii) training researchers in pediatric research techniques in order to address unmet pediatric research 

needs. 

‘‘(B) RESEARCH.—The Director of NIH shall, as appropriate, ensure that— 

‘‘(i) each consortium receiving an award under 

subparagraph (A) conducts or supports at least one 

category of research described in subparagraph (A)(i) 

and collectively such consortia conduct or support such 

categories of research; and 

‘‘(ii) one or more such consortia provide training 

described in subparagraph (A)(ii). 

‘‘(C) ORGANIZATION OF CONSORTIUM.—Each consortium 

receiving an award under subparagraph (A) shall— 

‘‘(i) be formed from a collaboration of cooperating 

institutions; 

‘‘(ii) be coordinated by a lead institution or institutions; 

‘‘(iii) agree to disseminate scientific findings, 

including from clinical trials, rapidly and efficiently, 

as appropriate, to— 

‘‘(I) other consortia; 

‘‘(II) the National Institutes of Health; 

‘‘(III) the Food and Drug Administration; 

‘‘(IV) and other relevant agencies; and 

‘‘(iv) meet such requirements as may be prescribed 

by the Director of NIH. 

‘‘(D) SUPPLEMENT, NOT SUPPLANT.—Any support 

received by a consortium under subparagraph (A) shall 

be used to supplement, and not supplant, other public 

or private support for activities authorized to be supported 

under this paragraph. 

‘‘(E) DURATION OF SUPPORT.—Support of a consortium 

under subparagraph (A) may be for a period of not to 

exceed 5 years. Such period may be extended at the discretion of the Director of NIH. 

‘‘(3) COORDINATION OF CONSORTIA ACTIVITIES.—The Director 

of NIH shall, as appropriate— 

‘‘(A) provide for the coordination of activities (including 

the exchange of information and regular communication) 

among the consortia established pursuant to paragraph 

(2); and 

‘‘(B) require the periodic preparation and submission 

to the Director of reports on the activities of each such 

consortium. 

‘‘(4) ASSISTANCE WITH REGISTRIES.—Each consortium 

receiving an award under paragraph (2)(A) may provide assistance, as appropriate, to the Centers for Disease Control and 

Prevention for activities related to patient registries and other 

surveillance systems upon request by the Director of the Centers for Disease Control and Prevention. 

‘‘(e) RESEARCH ON PEDIATRIC RARE DISEASES OR CONDITIONS.— In making awards under subsection (d)(2) for pediatric research 

consortia, the Director of NIH shall ensure that an appropriate 
S. 252—6 

number of such awards are awarded to such consortia that agree 

to— 

‘‘(1) consider pediatric rare diseases or conditions, or those 

related to birth defects; and 

‘‘(2) conduct or coordinate one or more multisite clinical 

trials of therapies for, or approaches to, the prevention, diagnosis, or treatment of one or more pediatric rare diseases or 

conditions.’’. 

TITLE III—CHIMP ACT AMENDMENTS 

SEC. 301. SHORT TITLE. 

This title may be cited as the ‘‘CHIMP Act Amendments of 

2013’’. 

SEC. 302. CARE FOR NIH CHIMPANZEES. 

(a) IN GENERAL.—Section 404K(g) of the Public Health Service 

Act (42 U.S.C. 283m(g)) is amended— 

(1) by amending paragraph (1) to read as follows: 

‘‘(1) IN GENERAL.—Of the amount appropriated for the 

National Institutes of Health, there are authorized to be appropriated to carry out this section and for the care, maintenance, 

and transportation of all chimpanzees otherwise under the 

ownership or control of the National Institutes of Health, and 

to enable the National Institutes of Health to operate more 

efficiently and economically by decreasing the overall Federal 

cost of providing for the care, maintenance, and transportation 

of chimpanzees— 

‘‘(A) for fiscal year 2014, $12,400,000; 

‘‘(B) for fiscal year 2015, $11,650,000; 

‘‘(C) for fiscal year 2016, $10,900,000; 

‘‘(D) for fiscal year 2017, $10,150,000; and 

‘‘(E) for fiscal year 2018, $9,400,000.’’; 

(2) by striking paragraph (2); 

(3) by redesignating paragraph (3) as paragraph (2); and 

(4) in paragraph (2), as so redesignated— 

(A) by striking ‘‘With respect to amounts reserved 

under paragraph (1)’’ and inserting ‘‘With respect to 

amounts authorized to be appropriated by paragraph (1)’’; 

and 

(B) by striking ‘‘board of directors’’ and inserting ‘‘Secretary in consultation with the board of directors’’. 

(b) GAO STUDY.—Not later than 2 years after the date of 

enactment of this Act, the Comptroller General of the United States 

shall conduct an independent evaluation, and submit to the appropriate committees of Congress a report, regarding chimpanzees 

under the ownership or control the National Institutes of Health. 

Such report shall review and assess— 

(1) the research status of such chimpanzees; 

(2) the cost for the care, maintenance, and transportation 

of such chimpanzees, including the cost broken down by— 

(A) research or retirement status; 

(B) services included in the care, maintenance, and 

transportation; and 

(C) location; 
S. 252—7 

(3) the extent to which matching requirements have been 

met pursuant to section 404K(e)(4) of the Public Health Service 

Act (42 U.S.C. 283m(e)(4)); and 

(4) any options for cost savings for the support and maintenance of such chimpanzees. 

(c) BIENNIAL REPORT.—Section 404K(g) of the Public Health 

Service Act (42 U.S.C. 283m(g)) is amended by adding at the end 

the following: 

‘‘(3) BIENNIAL REPORT.—Not later than 180 days after the 

date enactment of this Act, the Director of the National 

Institutes of Health shall submit to the Committee on Health, 

Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and 

Commerce and the Committee on Appropriations in the House 

of Representatives a report, to be updated biennially, 

regarding— 

‘‘(A) the care, maintenance, and transportation of the 

chimpanzees under the ownership or control of the National 

Institutes of Health; 

‘‘(B) costs related to such care, maintenance, and 

transportation, and any other related costs; and 

‘‘(C) the research status of such chimpanzees.’’. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.